NCI opens online platform to submit ideas about research for Cancer Moonshot [Correction]
Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)
[This is a correction - the link was incorrect] The Moonshot program is looking for ideas.. I submitted one on the Virtual Trial concept. Would be nice if everyone helped by commenting on it - which will bring it to their attention!
Go to https://cancerresearchideas.cancer.gov/a/dtd/Virtual-Trial/177937-39827
Posted on: 05/01/2016
NCI opens online platform to submit ideas about research for Cancer Moonshot
The National Cancer Institute (NCI), part of the National Institutes of Health has launched an online platform to enable the research community and the public to submit ideas on the National Cancer Moonshot efforts. Submissions will be considered by the Blue Ribbon Panel (BRP) of scientific experts and patient advocates as they develop the scientific direction at NCI for the initiative.
The announcement of this online platform coincides with the opening of the American Association for Cancer Research (AACR) Annual Meeting in New Orleans. Ideas for advancing progress against cancer may be submitted at CancerResearchIdeas.cancer.gov.
The Blue Ribbon Panel, whose members were announced on April 4 and which held its first meeting on April 11, will serve as a working group of the presidentially appointed National Cancer Advisory Board (NCAB). One of the first actions of the panel was to discuss the establishment of several proposed working groups to focus on specific topic areas. Ideas, which may range from cancer prevention to advancing understanding of the origins of cancer to reducing cancer health disparities, may be submitted in the following areas:
- Cancer clinical trials
- Data sharing
- Dissemination and population sciences
- Immunotherapy, combination therapy, and immunoprevention
- Pediatric cancer
- Tumor evolution and progression
- Other exceptional opportunities
The ideas that are submitted will be discussed and considered by the proposed working groups and the Blue Ribbon Panel as they deliberate about cancer research priorities and opportunities over the next few months. The panel will report its findings to the NCAB later this summer.
“The goal of the Moonshot Initiative is to accelerate progress in the fight against cancer by swiftly advancing knowledge from cutting-edge basic research to new prevention and treatment strategies for patients,” said NCI Acting Director Douglas Lowy, M.D. “The community involvement that the initiative garners will allow us to consider novel, creative ideas that might not otherwise have come to NCI’s attention.”
The feedback platform is just one way in which the public can provide ideas for accelerating progress in the fight against cancer through this initiative. Ideas can also be submitted by email, or by calling the Cancer Information Service at 1-800-4-CANCER.
To sign up for updates on the online platform and other aspects of the National Cancer Moonshot Initiative, please visit the initiative’s main website.
The National Cancer Institute leads the National Cancer Program and the NIH’s efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI website at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®
Click HERE to return to brain tumor news headlines